106Ruthenium brachytherapy for ciliary recurrence with supraciliary effusion in retinoblastoma

Jay Chhablani, Antonio Romanzo, Aubin Balmer, Alessia Pica, Marie Claire Gaillard, Raffaele Cozza, Raphal Moeckli, Francis L. Munier

Research output: Contribution to journalArticle

Abstract

Purpose: A 2-year-old boy with syndromic bilateral retinoblastoma resulting from a (del(13)(q12.3q14.3)) developed a recurrent tumor measuring 2.3×2.3mm at the ora serrata 15 months following last treatment. Methods: Ultrasound biomicroscopy (UBM) revealed a mass invading the ciliary body 6.6mm in diameter associated with a localized supraciliary effusion. Results: Complete tumor regression was achieved 1 month after brachytherapy with a 106Ruthenium plaque. There was no recurrence at 16 months. Conclusion: This is the first clinical demonstration of supraciliary effusion in recurrent retinoblastoma. Brachytherapy appears to be effective in the treatment of this type of recurrence.

Original languageEnglish
Pages (from-to)190-192
Number of pages3
JournalOphthalmic Genetics
Volume31
Issue number4
DOIs
Publication statusPublished - Dec 2010

    Fingerprint

Keywords

  • ciliary body recurrence
  • retinoblastoma
  • supraciliary effusion

ASJC Scopus subject areas

  • Ophthalmology
  • Pediatrics, Perinatology, and Child Health
  • Genetics(clinical)

Cite this

Chhablani, J., Romanzo, A., Balmer, A., Pica, A., Gaillard, M. C., Cozza, R., Moeckli, R., & Munier, F. L. (2010). 106Ruthenium brachytherapy for ciliary recurrence with supraciliary effusion in retinoblastoma. Ophthalmic Genetics, 31(4), 190-192. https://doi.org/10.3109/13816810.2010.499888